← All devices 
Clinical / medical-grade · Patch / sensor · by Abbott
Abbott FreeStyle Libre 2
The widely-used prior-gen CGM — FDA-cleared, accurate, broadly covered, with optional glucose alarms.
2020FreeStyle Libre 2
Late in cycle6 yr old
Prior generation to the FreeStyle Libre 3 / 3 Plus.
API access: Yes — restricted Raw data access: Yes — restricted Open source: Community
Clinical value
88/100
FDA-cleared iCGM, ages 4+
Empowerment
64/100
Clinician-centric data, Rx gate
Everyday value
58/100
14-day sensor, single-purpose
The previous-generation FreeStyle Libre, still one of the most widely used CGMs — FDA-cleared, accurate, broadly insurance-covered, with optional high/low glucose alarms, behind a prescription.
What it measures
Continuous interstitial glucose with optional real-time high/low alarms; 14-day sensor; integrates with automated insulin delivery on compatible systems.
Regulatory status
FDA 510(k)-cleared integrated CGM (iCGM, 2020), ages 4+, prescription. Superseded by the Libre 3 / 3 Plus but still sold and covered.
Validation & accuracy
Reported overall MARD ~9.3%; well validated and widely used in diabetes care.
Data control & export
Raw data: restricted — LibreView cloud (clinician dashboards) and LibreLinkUp caregiver sharing, with CSV export from LibreView; reader-based export more manual. API: restricted (LibreView).
Wearability & battery
A small round adhesive arm sensor, 14-day wear; no charging, replace each cycle. Discreet and comfortable.
Cost & access
Prescription; broadly covered by insurance and Medicare for eligible users.
Who it serves
People with diabetes who want accurate, covered CGM with optional alarms.
Who is left out or burdened
Prescription gatekeeping; clinic-centric data model; ongoing sensor cost.
✓ Strengths
- FDA-cleared iCGM with optional high/low alarms
- Broadly insurance/Medicare covered
- Cleared for ages 4+; AID-compatible
- LibreView clinician sharing and CSV export
✕ Weaknesses
- Prescription required
- Clinic-centric data model; reader export is manual
- Superseded by the Libre 3 / 3 Plus
- Ongoing sensor cost
88
Why this clinical score. A cleared, well-validated iCGM with optional alarms and AID compatibility — near the top of the clinical axis, just below the newer Libre 3.
64
Why this empowerment score. Real export and caregiver sharing exist, but the clinic-centric model and a prescription cap empowerment mid-range.
58
Why this everyday score. Comfortable and forgettable with no charging, but single-purpose with recurring swaps.
Latest news
Reviews & coverage
Reviewers and diabetes communities credit Libre 2 with affordable, accurate scanning/alerts that made CGM mainstream. Gripes are the optional-alarm setup, cost without coverage and adhesive/sensor reliability.
Summary is a draft synthesis of public coverage, not an endorsement. Links open a search of each outlet.
Reddit communities
Independent user communities where this device (or its category) is discussed.
Get it · manuals & support
Draft profile · public-source review, June 2026 · scores describe direction and degree, not buying advice. News, links, and prices change — verify with the manufacturer. Image is representative.